Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
16%
AL Amyloidosis
16%
Amyloidosis
11%
Asparaginase
16%
Bence Jones Protein
8%
Bevacizumab
16%
Bortezomib
27%
Brain Toxicity
16%
Chromosome Aberration
5%
Critical Illness
19%
Cyclin D1
16%
Cytokine
16%
Diseases
19%
Endothelial Protein C Receptor
16%
Epidermal Growth Factor Receptor 2
11%
Gamma Urogastrone
11%
Heart Arrest
16%
Hematologic Malignancy
5%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
16%
Hypercalcaemia
8%
Ischemia
12%
Lactate Dehydrogenase
16%
Lactic Acid
54%
Lenalidomide
30%
Metastatic Colorectal Cancer
16%
Microdialysis
49%
Multiple Myeloma
83%
Multiple Organ Failure
16%
Myeloma
18%
Observational Study
8%
Out of Hospital Cardiac Arrest
16%
Overall Survival
35%
Progression Free Survival
16%
Proteinuria
8%
Pyruvic Acid
29%
Sepsis
33%
Septic Shock
18%
Subarachnoid Hemorrhage
16%
Tau Protein
5%
Thalidomide
22%
Immunology and Microbiology
Adiponectin
16%
Adipose Tissue
55%
Angiopoietin 2
16%
Cortisol
18%
CXCL13
16%
CXCR5
16%
Cytokine
33%
Endothelial Protein C Receptor
16%
Gamma Urogastrone
16%
Glycerol
47%
Hemocyte
16%
Infectious Agent
16%
Inflammation Response
18%
Interleukin 10
5%
Interleukin 6
5%
Interleukin 8
5%
Interstitial Fluid
14%
Interstitium
16%
Lactate Blood Level
21%
Lactate Dehydrogenase Blood Level
13%
Lipolysis
18%
Metabolite
16%
Microdialysis
100%
Multiple Myeloma
33%
Resistin
16%
Superficial Fascia
16%
Tissue Level
12%
Tissue Metabolism
37%
Medicine and Dentistry
Adiponectin
16%
Adipose Tissue
16%
APACHE II
5%
Asparaginase
16%
Autologous Stem Cell Transplantation
5%
Bence Jones Protein
8%
Bortezomib
8%
Broad-Spectrum Antibiotic
5%
Burkitt's Lymphoma
16%
Central Nervous System Infection
16%
Coronary Flow Reserve
16%
Cytokine
16%
Diseases
7%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
16%
Hydrocortisone
19%
Hypercalcaemia
8%
Interstitium
16%
Lactate Dehydrogenase
16%
Lactic Acid
19%
Lenalidomide
8%
Lipolysis
19%
Metalloprotease Inhibitor
16%
Multiple Myeloma
50%
Multiple Organ Dysfunction Syndrome
16%
Multivariate Analysis
6%
Myeloma
12%
Overall Survival
18%
Progesterone Receptor
8%
Progression Free Survival
16%
Resistin
16%
Sepsis
19%
Septic Shock
10%
Systemic Mycosis
16%
Thalidomide
8%
Tissue Metabolism
16%
Toxic Encephalopathy
16%
Urothelial Cancer
16%
Uterine Tube Carcinoma
16%
